Details for Patent: 7,587,988
✉ Email this page to a colleague
Which drugs does patent 7,587,988 protect, and when does it expire?
Patent 7,587,988 protects SYMBICORT and is included in one NDA.
Protection for SYMBICORT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-nine patent family members in thirty-two countries.
Summary for Patent: 7,587,988
| Title: | Inhaler device counter |
| Abstract: | Inhaler counter (20) comprising a counter housing (390), a rocker arm (200) with a pawl (210), the rocker arm being pivotally supported by the housing and arranged to perform a rocker movement in response to a linear actuation motion, a return spring (220) for resetting the rocker arm, a ratchet wheel (230) engagable with the pawl to convert the movement of the rocker arm into an incremental rotational motion of an axle arrangement (240) advancing a display means (60), the axle arrangement further comprising a back rotation prevention means (280) in the form of a spring loaded friction brake and a worm gear, the display means comprising rotatable indicator means (120) with teeth that engage the worm-gear and a stationary scale. |
| Inventor(s): | Bowman; Nic (Cambridge, GB), Bradshaw; Douglas (Royston Herts, GB), Sorby; Lennart (Uppsala, SE) |
| Assignee: | AstraZeneca AB (Sodertalje, SE) |
| Application Number: | 11/570,747 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,587,988 |
|
Patent Claim Types: see list of patent claims | Delivery; Use; Device; |
Drugs Protected by US Patent 7,587,988
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-001 | Jul 21, 2006 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Astrazeneca | SYMBICORT | budesonide; formoterol fumarate dihydrate | AEROSOL, METERED;INHALATION | 021929-002 | Jul 21, 2006 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,587,988
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Sweden | 0500857 | Apr 14, 2005 |
| PCT Information | |||
| PCT Filed | April 10, 2006 | PCT Application Number: | PCT/SE2006/000423 |
| PCT Publication Date: | October 19, 2006 | PCT Publication Number: | WO2006/110080 |
International Family Members for US Patent 7,587,988
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 055910 | ⤷ Try a Trial | |||
| Austria | 10425 | ⤷ Try a Trial | |||
| Austria | 10426 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
